Actively Recruiting
Nurse-led Physician-supported Care for Patients With Chronic Kidney Disease and Multimorbidity
Led by Alexandra Hospital · Updated on 2024-04-18
220
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
Sponsors
A
Alexandra Hospital
Lead Sponsor
N
National University Hospital, Singapore
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic kidney disease (CKD) is a prevalent chronic disease and is often intertwined with the management of cardiovascular disease and the optimization of metabolic risk factors. In light of steeply rising rates of end-stage kidney disease (ESKD) and increased healthcare resource utilization by CKD patients, the investigators propose that the role of nurses could be expanded to support the care of CKD patients in the community. A total of 220 patients will be randomized (1:1) to the intervention or control groups (usual care). The intervention entails enrolment into a nurse-led, physician-supported programme (INTEGREAT-CKD), comprising outpatient consultations and community-based ambulatory monitoring and counselling primarily driven by CKD-trained advanced practice nurses (APNs) and healthcare professionals conducted over 6 months. Patient-reported outcomes like health-related quality of life (HRQOL), as measured by EQ-5D and KDQOL, CKD self-management score and CKD health literacy will be assessed at baseline and after 6 months. The primary outcome is CKD self-management. Other secondary outcomes to be assessed and tracked including achievement of clinical targets relevant to slowing down CKD progression, attainment of CKD best practice guidelines as specified in the KDIGO CKD Evaluation and Management guidelines 2020.
CONDITIONS
Official Title
Nurse-led Physician-supported Care for Patients With Chronic Kidney Disease and Multimorbidity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 21 years and above
- Diagnosed with CKD Stages 3B and above (estimated GFR ≤ 44 mL/min/1.73m2 with evidence of kidney damage)
- Have one or more sub-optimally managed parameters in blood pressure control, glycemic control, or fluid status management
You will not qualify if you...
- Pregnancy
- End stage kidney disease
- Currently enrolled or enrolled in any structured outpatient or community CKD program for at least six months before or during study enrollment
- Dementia and/or cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wei Zhen Hong
Singapore, Singapore, 119228
Actively Recruiting
Research Team
W
Wei Zhen Hong, MBBS, MRCP, MMed
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here